For parents anxiously awaiting the opportunity to vaccinate their young children for Covid-19, the news that Pfizer was submitting their trial data to the FDA with the hopes of gaining approval for the 5-11 age group by Halloween has been exciting.
Read more at Forbes - 6 min. read
No comments:
Post a Comment